tiprankstipranks
Evome Medical Technologies Thrives with New Strategies
Company Announcements

Evome Medical Technologies Thrives with New Strategies

Story Highlights
  • Evome Medical Technologies achieved $424,000 in adjusted EBITDA and reduced debt by $1.4 million.
  • The company launched a new distribution company and appointed Bill Garbarini as COO.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.

Salona Global Medical Device (TSE:EVMT) has released an update.

Pick the best stocks and maximize your portfolio:

Evome Medical Technologies reported a positive financial performance in the third quarter of 2024, achieving $424,000 in adjusted EBITDA and reducing debt by $1.4 million. The company has also expanded its product offerings by launching a new distribution company and appointing Bill Garbarini as the Chief Operating Officer. These strategic moves are part of Evome’s efforts to stabilize its business and strengthen its market position.

For further insights into TSE:EVMT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskEvome Medical Technologies Approves New Share Plan
TipRanks Canadian Auto-Generated NewsdeskSalona Global Unveils Strategic Growth Plan for Evome Medical
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App